Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Strategic Asset Allocation Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Strategic Asset Allocation Index of 9.0% as of September 2023. Strategic assets (PP&E of CN¥576.74 Million plus long-term investments of CN¥-) total CN¥576.74 Million, measured against net assets of CN¥6.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see 002932 market cap overview.
SAAI
Strategic Assets
PP&E
Net Assets
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Strategic Asset Allocation Index (2015–2022)
This chart shows how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of September 2023, the index stands at 9.0%, representing strategic assets of CN¥576.74 Million against net assets of CN¥6.39 Billion CNY. See Wuhan Easy Diagnosis Biomedicine Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore 002932 net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.8% | CN¥525.97 Million | CN¥525.97 Million | CN¥- | CN¥6.77 Billion | ▼ -0.8 pp |
| 2021 | 8.5% | CN¥243.47 Million | CN¥243.47 Million | CN¥- | CN¥2.85 Billion | ▼ -2.5 pp |
| 2020 | 11.1% | CN¥123.26 Million | CN¥123.26 Million | CN¥- | CN¥1.11 Billion | ▼ -4.7 pp |
| 2019 | 15.8% | CN¥97.26 Million | CN¥97.26 Million | CN¥- | CN¥615.62 Million | ▲ +0.6 pp |
| 2018 | 15.2% | CN¥90.02 Million | CN¥90.02 Million | CN¥- | CN¥592.59 Million | ▼ -13.5 pp |
| 2017 | 28.7% | CN¥69.66 Million | CN¥69.66 Million | CN¥- | CN¥242.93 Million | ▲ +1.8 pp |
| 2016 | 26.9% | CN¥47.12 Million | CN¥47.12 Million | CN¥- | CN¥175.08 Million | ▲ +16.2 pp |
| 2015 | 10.7% | CN¥12.38 Million | CN¥12.38 Million | CN¥- | CN¥115.39 Million | — |